Failure of Daratumumab Therapy for Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, Skin Changes Syndrome
J Clin Neuromuscul Dis
.
2021 Sep 1;23(1):56-58.
doi: 10.1097/CND.0000000000000370.
Authors
Bo Leung
1
,
Thomas Nelson
,
Rafer Willenberg
,
Matthew Burford
Affiliation
1
Department of Neurology, Cedars-Sinai, Los Angeles, CA.
PMID:
34431806
DOI:
10.1097/CND.0000000000000370
No abstract available
MeSH terms
Antibodies, Monoclonal
Humans
POEMS Syndrome* / drug therapy
Polyneuropathies* / drug therapy
Substances
Antibodies, Monoclonal
daratumumab